Vumerity and Blushing - a phase IV clinical study of FDA data

Summary:

Blushing is reported as a side effect among people who take Vumerity (diroximel fumarate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Gabapentin, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Blushing when taking Vumerity. It is created by eHealthMe based on reports of 9,775 people who have side effects when taking Vumerity from the FDA, and is updated regularly.

What is Vumerity?

Vumerity has active ingredients of diroximel fumarate. eHealthMe is studying from 9,781 Vumerity users. Check the latest studies of Vumerity.

What is Blushing?

Blushing is found to be associated with 3,222 drugs and 2,919 conditions by eHealthMe. Check the latest studies of Blushing.

On Apr, 25, 2026

9,775 people reported to have side effects when taking Vumerity.
Among them, 1,638 people (16.76%) have Blushing.

Among these 1,638 people:

* Approximation only. Some reports may have incomplete information.

Do you take Vumerity and have Blushing?

- Check whether Blushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vumerity:

Vumerity (9,781 reports)

Blushing treatments and more:

Blushing (117,676 reports)

How severe was Blushing and when was it recovered:

Blushing in Vumerity

Expand to all the drugs that have ingredients of diroximel fumarate:

Blushing and drugs with ingredients of diroximel fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vumerity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blushing:

Blushing (3,222 drugs)

Browse all the conditions that are associated with Blushing:

Blushing (2,919 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diroximel fumarate (the active ingredients of Vumerity) and Vumerity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.